Total medical devices industry M&A deals in Q2 2019 worth $14.71bn were announced globally, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked an increase of 78.8% over the previous quarter and a rise of 72.1% when compared with the last four-quarter average, which stood at $8.54bn.

Comparing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $13.56bn. At the country level, the US topped the list in terms of deal value at $13.43bn.

In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

The top country in terms of M&A deals activity in Q2 2019 was the US with 47 deals, followed by the UK with seven and Germany with six.

In 2019, as of the end of Q2 2019, medical devices M&A deals worth $22.94bn were announced globally, marking an increase of 84.7% year on year.

Medical devices industry M&A deals in Q2 2019: Top deals

The top five medical devices industry M&A deals accounted for 94.3% of the overall value during Q2 2019.

The combined value of the top five medical devices industry M&A deals stood at $13.87bn, against the overall value of $14.71bn recorded for the quarter. The top announced medical devices industry M&A deal tracked by GlobalData in Q2 2019 was 3M‘s $6.73bn acquisition of Acelity.

In second place was the $5.8bn acquisition of Medidata Solutions by Dassault Systemes and in third place was Bracco Imaging’s $475m acquisition of Blue Earth Diagnostics.

The $465m acquisition of VertiFlex by Boston Scientific and Ethicon US’s asset transaction with Takeda Pharmaceutical for $400m held fourth and fifth positions, respectively.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.